幾十篇文獻(xiàn)

需求幾十篇文獻(xiàn) 1.Regulation Mechanism of MicroRNAs in Non-Small Cell Lung Cancer 2、J Clin Gastroenterol. 2016 Jan;50(1):e1-7. Gastroesophageal Reflux Disease: Cross-Sectional Study Demonstrating Rising Prevalence in a Chinese Population. Tan VP1, Wong BC, Wong WM, Leung WK, Tong D, Yuen MF, Fass R. 3、Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Eusebi LH, Ratnakumaran R, Yuan Y, Solaymani-Dodaran M, Bazzoli F, Ford AC. Gut. 2018 Mar;67(3):430-440. 4、The prevalence and risk factors of reflux esophagitis among adult Chinese population in Taiwan. Chen TS, Chang FY. J Clin Gastroenterol. 2007 Oct;41(9):819-22. 5、 Circulation. 1998 Nov 24;98(21):2282-9. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Senni M1, Tribouilloy CM, Rodeheffer RJ, Jacobsen SJ, Evans JM, Bailey KR, Redfield MM. 6、 Anesth Analg. 2018 Nov 9. doi: 10.1213/ANE.0000000000003887. [Epub ahead of print] Side Effect Rates of Opioids in Equianalgesic Doses Via Intravenous Patient-Controlled Analgesia: A Systematic Review and Network Meta-analysis. 7. Association between proton pump inhibitors use and risk of gastric cancer in patients with GERD 8.Macromolecules, 1983, 16 (8), pp 1367-1374DOI: 10.1021/ma00242a019 Publication Date: August 1983 ACS Legacy Archive 9、Beneficial effects of tolvaptan on atrial remodeling induced by chronic intermittent hypoxia in rats Kai Zhang Zuowang Ma Weiding Wang Ruimeng Liu Yue Zhang Meng Yuan Guangping Li 10、Vascular. 2018 Dec;26(6):626-633. Prognostic factors of ulcer healing and amputation-free survival in patients with critical limb ischemia. 嚴(yán)重肢體缺血患者潰瘍愈合和無截肢生存的預(yù)后因素 Furuyama T, Onohara T, Yamashita S, Yoshiga R, Yoshiya K, Inoue K, Morisaki K, Kyuragi R, Matsumoto T, Maehara Y. 11、Curr Drug Discov Technol. 2018 Oct 8. Aripiprazole: An FDA Approved Bioactive Compound to treat schizophrenia-A Mini Review. 阿立哌唑：一種FDA批準(zhǔn)的治療精神分裂癥的生物活性化合物——一篇綜述 Kumar A, Singh H, Mishra A, Mishra AK. 12、J Child Adolesc Psychopharmacol. 2018 Dec;28(10):682-689. Aripiprazole/Methylphenidate Combination in Children and Adolescents with Disruptive Mood Dysregulation Disorder and Attention-Deficit/Hyperactivity Disorder: An Open-Label Study. 阿立哌唑/哌醋甲酯聯(lián)合治療兒童和青少年破壞性情緒失調(diào)癥和注意力缺陷/多動(dòng)障礙：一項(xiàng)開放標(biāo)簽研究 Pan PY, Fu AT, Yeh CB 13、 ADPKD J Nephrol. 2018 Dec;31(6):961-966. Tolvaptan in Japanese patients with later-stage autosomal dominant polycystic kidney disease.托伐普坦用于晚期ADPKD日本患者 Oguro M, Kogure Y, Hoshino J, Ubara Y, Mizuno H, Sekine A, Kawada M, Sumida K, Hiramatsu R, Hasegawa E, Yamanouchi M, Hayami N, Suwabe T, Sawa N, Takaichi K. 14、瑞巴派特 Digestion. 2018 Nov 28:1-8. Chemopreventive Effect of Rebamipide against Gastric Cancer in Patients who undergo Endoscopic Resection for Early Gastric Neoplasms: A Nationwide Claims Study.瑞巴派特對(duì)早期胃腫瘤內(nèi)鏡切除術(shù)患者的化學(xué)預(yù)防作用：一項(xiàng)全國性的聲稱研究 Seo GH, Lee H. 7、德拉馬尼 《WHO耐多藥結(jié)核病/利福平耐藥結(jié)核病治療指南2018更新版》摘譯 WHO網(wǎng)站原文鏈接： https://www.who.int/tb/features_archive/updated-treatment-guidelines-multigrug-rifampicin-resistant-TB/en/ 8、Bone Marrow Transplant. 2018 Oct 19. Preconditioning with fludarabine, busulfan and cytarabine versus standard BuCy2 for patients with acute myeloid leukemia: a prospective, randomized phase II study. 氟達(dá)拉濱、白消安和阿糖胞苷預(yù)處理與標(biāo)準(zhǔn)BuCy2預(yù)處理方案治療急性髓性白血病患者的比較：一項(xiàng)前瞻性隨機(jī)II期臨床研究 Zhang WP, Wang ZW, Hu XX, Chen J, Yang D, Song XM, Gao L, Ni X, Chen L, Xia XX, Zhou H, Tang GS, Cheng H, Luo YR, Li HM, Yang JM, Wang JM.